Investor Relations Home

Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

Accuray does not assume a duty to update information on this website, except through the normal quarterly financial press releases and regulatory filings.

ARAY (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.05 (1.11%)
Data as of Sep 25, 2017 4:00 p.m. ET
Refresh quote
Stock chart for: ARAY.O.  Currently trading at $4.45 with a 52 week high of $6.39 and a 52 week low of $3.60.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Press Releases

Accuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017
SUNNYVALE, Calif., Sept. 20, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact™ Systems, and unique software solutions, will be shared by leading ra... 
Sep 20, 2017
Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results
SUNNYVALE, Calif., Aug. 22, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2017. Q4 Fiscal 2017 and Recent Highligh... 
Aug 22, 2017

Upcoming Investor Event

There are currently no events scheduled.
Some documents in the Investor Relations section require that you have Adobe Acrobat Reader® installed in order to view files in PDF format. Download the newest version of Acrobat Reader